CoChat

Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure

Open access
Stewart, Garrick C., Weintraub, Joanne R., Pratibhu, Parakash P., Semigran, Marc J., Camuso, Janice M., Brooks, Kimberly, Tsang, Sui W., Anello, Mary Susan, Nguyen, Viviane T., Lewis, Eldrin F., Nohria, Anju, Desai, Akshay S., Givertz, Michael M., Stevenson, Lynne W. · 2010 · Journal of Cardiac Failure
Cited by 130

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background Indications for implantable cardioverter-defibrillators (ICDs) in heart failure (HF) are expanding and may include more than 1 million patients. This study examined patient expectations from ICDs for primary prevention of sudden death in HF. Methods and Results Study participants (n = 105) had an EF <35% and symptomatic HF, without history of ventricular tachycardia/fibrillation or syncope. Subjects completed a written survey about perceived ICD benefits, survival expectations, and circumstances under which they might deactivate defibrillation. Mean age was 58, LVEF 21%, 40% were New York Heart Association Class III-IV, and 65% already had a primary prevention ICD. Most patients anticipated more than10 years survival despite symptomatic HF. Nearly 54% expected an ICD to save ≥50 lives per 100 during 5 years. ICD recipients expressed more confidence that the device would save their own lives compared with those without an ICD (P < .001). Despite understanding the ease of deactivation, 70% of ICD recipients indicated they would keep the ICD on even if dying of cancer, 55% even if having daily shocks, and none would inactivate defibrillation even if suffering constant dyspnea at rest. Conclusions HF patients anticipate long survival, overestimate survival benefits conferred by ICDs, and express reluctance to deactivate their devices even for end-stage disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cardfail.2009.09.003

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 44

  1. 2006, 2006 Comprehensive Heart Failure Practice Guideline, J Cardiac Failure, 12, e1, 10.1016/j.cardfail.2005.11.005 · DOI · Paper page
  2. Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
  3. Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
  4. Desai, 2004, Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials, JAMA, 292, 2874, 10.1001/jama.292.23.2874 · DOI · Paper page
  5. Rosamond, 2008, Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 117, e25, 10.1161/CIRCULATIONAHA.107.187998 · DOI · Paper page
  6. Kannel, 1988, Cardiac failure and sudden death in the Framingham Study, Am Heart J, 115, 869, 10.1016/0002-8703(88)90891-5 · DOI · Paper page
  7. Hammill, 2007, Review of the registry's first year, data collected, and future plans, Heart Rhythm, 4, 1260, 10.1016/j.hrthm.2007.07.021 · DOI
  8. Tung, 2008, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, J Am Coll Cardiol, 52, 1111, 10.1016/j.jacc.2008.05.058 · DOI · Paper page
  9. Setoguchi, 2007, Repeated hospitalizations predict mortality in the community population with heart failure, Am Heart J, 154, 260, 10.1016/j.ahj.2007.01.041 · DOI · Paper page
  10. Carson, 2005, Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial, J Am Coll Cardiol, 46, 2329, 10.1016/j.jacc.2005.09.016 · DOI · Paper page
  11. Sanders, 2005, Cost-effectiveness of implantable cardioverter-defibrillators, N Engl J Med, 353, 1471, 10.1056/NEJMsa051989 · DOI · Paper page
  12. Mark, 2006, Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Circulation, 114, 135, 10.1161/CIRCULATIONAHA.105.581884 · DOI · Paper page
  13. Ellenbogen, 2006, Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?, Circulation, 113, 776, 10.1161/CIRCULATIONAHA.105.561571 · DOI · Paper page
  14. Moss, 2004, Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, 3760, 10.1161/01.CIR.0000150390.04704.B7 · DOI · Paper page
  15. Ahmad, 2000, Patients' attitudes toward implanted defibrillator shocks, Pacing Clin Electrophysiol, 23, 934, 10.1111/j.1540-8159.2000.tb00877.x · DOI · Paper page
  16. Passman, 2007, Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study, Arch Intern Med, 167, 2226, 10.1001/archinte.167.20.2226 · DOI · Paper page
  17. Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact, J Am Coll Cardiol, 51, 1357, 10.1016/j.jacc.2007.09.073 · DOI · Paper page
  18. Sola, 2005, Implantable cardioverter-defibrillators, induced anxiety, and quality of life, Mayo Clin Proc, 80, 232, 10.4065/80.2.232 · DOI
  19. Dunbar, 1993, Internal cardioverter defibrillator device discharge: experiences of patients and family members, Heart Lung, 22, 494
  20. Prudente, 2006, Psychological indices and phantom shocks in patients with ICD, J Interv Card Electrophysiol, 15, 185, 10.1007/s10840-006-9010-z · DOI
  21. Thomas, 2006, Quality of life and psychological status of patients with implantable cardioverter defibrillators, Am J Crit Care, 15, 389, 10.4037/ajcc2006.15.4.389 · DOI · Paper page
  22. Epstein, 2008, Circulation, 117, 2820, 10.1161/CIRCUALTIONAHA.108.189741 · DOI · Paper page
  23. Torrance, 1987, Utility approach to measuring health-related quality of life, J Chronic Dis, 40, 593, 10.1016/0021-9681(87)90019-1 · DOI · Paper page
  24. Goldenberg, 2006, Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II, Circulation, 113, 2810, 10.1161/CIRCULATIONAHA.105.577262 · DOI · Paper page
  25. Moss, 2004, Temporal aspects of improved survival with the implanted defibrillator (MADIT-II), Am J Cardiol, 94, 312, 10.1016/j.amjcard.2004.04.025 · DOI
  26. Stevenson, 2006, Cost-effectiveness of ICDs, N Engl J Med, 354, 205, 10.1056/NEJMc052976 · doi:10.1056/nejmc052976
  27. Zwanziger, 2006, The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II, J Am Coll Cardiol, 47, 2310, 10.1016/j.jacc.2006.03.032 · DOI · Paper page
  28. 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
  29. Goldenberg, 2008, Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction, J Am Coll Cardiol, 51, 288, 10.1016/j.jacc.2007.08.058 · DOI · Paper page
  30. Zareba, 2005, Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population), American J Cardiol, 95, 1487, 10.1016/j.amjcard.2005.02.021 · DOI
  31. Mozaffarian, 2007, Prediction of mode of death in heart failure: the Seattle Heart Failure Model, Circulation, 116, 392, 10.1161/CIRCULATIONAHA.106.687103 · DOI · Paper page
  32. Teuteberg, 2006, Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium, J Cardiac Failure, 12, 47, 10.1016/j.cardfail.2005.08.001 · DOI
  33. Sears, 2002, Quality of life and psychological functioning of ICD patients, Heart (Br Cardiac Soc), 87, 488, 10.1136/heart.87.5.488 · DOI · Paper page
  34. Lewis, 2006, Withdrawing implantable defibrillator shock therapy in terminally ill patients, Am J Med, 119, 892, 10.1016/j.amjmed.2006.01.017 · DOI
  35. Berger, 2005, The ethics of deactivating implanted cardioverter defibrillators, Ann Intern Med, 142, 631, 10.7326/0003-4819-142-8-200504190-00012 · DOI · Paper page
  36. Mueller, 2003, Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life, Mayo Clin Proc, 78, 959, 10.1016/S0025-6196(11)63143-1 · doi:10.1016/s0025-6196(11)63143-1
  37. Stevenson, 2006, Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure, J Cardiac Failure, 12, 407, 10.1016/j.cardfail.2006.06.001 · DOI
  38. Politi, 2007, Communicating the uncertainty of harms and benefits of medical interventions, Med Decis Making, 27, 681, 10.1177/0272989X07307270 · DOI · Paper page
  39. Allen, 2008, Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure, JAMA, 299, 2533, 10.1001/jama.299.21.2533 · DOI · Paper page
  40. Lewis, 2001, Preferences for quality of life or survival expressed by patients with heart failure, J Heart Lung Transplant, 20, 1016, 10.1016/S1053-2498(01)00298-4 · DOI · Paper page
  41. Yancy, 2008, Predicting life expectancy in heart failure, JAMA, 299, 2566, 10.1001/jama.299.21.2566 · DOI
  42. Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, New Engl J Med, 359, 1009, 10.1056/NEJMoa071098 · DOI · Paper page
  43. van der Weijden, 2008, Koelewijn-van Loon MS. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice, Curr Opin Cardiol, 23, 471, 10.1097/HCO.0b013e32830b35f6 · DOI
  44. Goodyear-Smith, 2008, Patients prefer pictures to numbers to express cardiovascular benefit from treatment, Ann Family Med, 6, 213, 10.1370/afm.795 · DOI

Cited by

Metadata

Authors
Stewart, G. C., Weintraub, J. R., Pratibhu, P. P., Semigran, M. J., Camuso, J. M., Brooks, K., Tsang, S. W., Anello, M. S., Nguyen, V. T., Lewis, E. F., Nohria, A., Desai, A. S., Givertz, M. M., & Stevenson, L. W.
Venue
Journal of Cardiac Failure
Publisher
Elsevier BV
Published
2010-02
Volume
16
Issue
2
Pages
106-113
ISSN
1071-9164 (ISSN-L)
OpenAlex
W1984358938
Cited by
130
References
8
FWCI
5.34
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.